The Energy Code

Scar Reset: Microneedling + Light + Methylene Blue (The Keloid Breakthrough)

Most people treat scars like an aesthetic afterthought, but hypertrophic scars and keloids are biologically active tissue: itchy, painful, stiff, inflamed, and often stubbornly persistent. In this Energy Code Deep Dive, Dr. Mike Belkowski breaks down a randomized double-blind clinical trial using a synergistic 3-part approach: microneedling + photodynamic therapy + methylene blue as the photosensitizer.

We walk through the exact protocol (5 weekly sessions), how results were measured (JSS + POSAS), and what actually improved — thickness, stiffness, pain, itching, flexibility, pigmentation, vascularity, and patient satisfaction. We also discuss why controlled ROS under photodynamic therapy is different from chronic oxidative stress, why keloids may respond better to 1% methylene blue, and what “resetting the remodeling environment” really means.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Redefining scar quality: A synergistic approach with micro-needling and photodynamic therapy using methylene blue as a photosensitizer: a randomized clinical trial

-

Key Quotes From Dr. Mike:

“Scars aren’t just leftover tissue... they’re often biologically active.”

“Microneedling opens the pathway. Light delivers the signal. Methylene blue is the photochemical tool.”

“ROS (reactive oxygen species) isn’t ‘bad’— chronic ROS is bad. Controlled ROS can be therapeutic.”

“If you want to change tissue outcomes, you often have to change the tissue environment.”

“Methylene blue isn’t just a ‘mitochondria molecule'. In the right context, it’s a precision photochemical lever.”

-

Key points

•  

• Scars are biology, not just cosmetics; keloids/hypertrophic scars can stay inflamed and symptomatic.

• Trial design: randomized double-blind; 37 patients / 94 scars; 5 sessions, weekly.

• 4 groups: keloid vs hypertrophic × 0.1% vs 1% methylene blue.

• Protocol: microneedling (≈1–3 mm) → apply MB → occlude 30 min → light 15 min.

• Measured with JSS + POSAS (clinician + patient symptoms).

• Severity drop: JSS score fell roughly 14.69 → 4.69 by 6 months.

• POSAS: ~50% improvement after treatment; stable through 6 months.

• Biggest symptom wins: stiffness ↓ ~71%, itching ↓ ~70%, pain ↓ ~69%.

• 1% MB tended to outperform 0.1% for keloids (stronger photosensitizing effect/penetration).

• Low adverse events; keloid recurrence ~2% at 6 months; none reported for hypertrophic scars in that window.

• Mechanism logic: microneedling “restarts remodeling” + MB-PDT generates targeted ROS to modulate fibroblasts/collagen/inflammation.

• Limitations: small sample, no untreated control, subjective scales, limited objective imaging, follow-up only 6 months.

-

Episode timeline

• 0:19–1:31 Why scars are biology + the 3-part stack (microneedling + PDT + methylene blue)

• 1:36–2:17 Hypertrophic vs keloid + why standard care struggles (recurrence/side effects)

• 2:20–4:25 Trial setup: 37 patients / 94 scars, 4 groups, 5 weekly sessions + parameters

• 4:25–5:03 Outcomes measured: JSS + POSAS (clinician + patient symptoms)

• 5:05–6:13 Results: big drops in severity + symptom relief (stiffness/itching/pain)

• 6:13–7:37 Dose logic: 1% vs 0.1% MB + “controlled ROS” explanation

• 7:44–9:48 Mechanism: fibroblasts/collagen remodeling + why the combo is synergistic

• 9:51–10:48 Safety + recurrence + limitations (and what future trials need)

• 11:00–14:18 BioLight philosophy: stacking inputs, changing the environment, next steps

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

Biohacking Isn’t a Stack — It’s a Science: The Mitochondria-First Framework That Cuts Through the Noise

This episode is a graduate-seminar style scholarly review of biohacking; not as a vibe or a shopping list, but as an ecosystem of claims, evidence types, incentives, and failure modes. Dr. Mike Belkowski walks through peer-reviewed biochemical arguments, academic frameworks, consumer books, surveys, mainstream media translation, and manifesto-style writing — then filters it all through one lens: mitochondria, redox balance, inflammation control, cellular cleanup, and the upstream metabolic terrain that determines whether “hacks” create resilience or just add noise.

You’ll learn why changing 12 variables at once isn’t a protocol (it’s a story), why wearables are dashboards (not engines), how constraints like sleep and circadian rhythm govern everything downstream, and how to use evidence-tiering to separate real effects from compelling narratives. The end result is a practical, mitochondria-first framework: define outcomes, stabilize the baseline, add one lever at a time, and let measurement be the referee... not your identity.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

​“Biohacking is not one discipline, it’s an ecosystem.”

“You can feel like you’re doing a lot while actually destabilizing your physiology.”

“People change too many variables too quickly — they never stabilize long enough to see what’s helping.”

“The stress of tracking becomes a biological stressor.”

“A real biohack improves the slope of recovery and the durability of function.”

-

Key points

• Biohacking is an ecosystem, not a single discipline; it contains truth, hype, and ideology.

• The scholarly move: classify claims by mechanism, evidence type, and limits.

• Real “biohacking” = shifting upstream terrain (metabolic state), not adding tricks.

• City analogy: fix the power grid (mitochondria/redox/inflammation) before buying “better cars” (more tools).

• Maximalist stacks (12 changes at once) create stories, not causal protocols.

• Health is constrained by fundamentals: sleep, circadian rhythm, movement, nutrients, stress load.

• Wearables are dashboards: they inform iteration, but don’t change the engine by themselves.

• Surveys show adoption truth: protocols must be sustainable (time/cost barriers matter).

• Media rewards novelty → often overemphasizes shortcuts and underemphasizes constraints.

• Manifesto writing can weaponize mitochondrial language into overconfident worldviews.

• Common failure modes: novelty addiction, metric worship, evidence flattening, baseline neglect, context blindness.

• Use evidence tiers to guide safety and precision (don’t treat anecdotes like RCTs).

• Build a stack like a scientist: one goal, few metrics, one variable at a time.

• A “real stack” is earned through validated iteration, not purchased.

-

Episode timeline

• 0:02–1:31 — Setup: “scholarly review” of biohacking through a mitochondria-first lens; sources overview

• 1:31–4:57 — Biohacking = ecosystem; classification; metabolic terrain + “city/grid” analogy

• 4:57–8:15 — Maximalist stack critique; constraints; dashboards vs engines; measurement vs entertainment

• 8:15–10:52 — Consumer books + surveys + media framing: adoption, hype incentives, sustainability

• 10:52–12:57 — Manifesto layer: how mitochondria language can out-run evidence

• 12:57–14:49 — Failure modes (novelty addiction, metric worship, evidence flattening, baseline neglect, context blindness)

• 14:49–19:47 — Evidence-tiering + what “effectiveness” really means (subjective → functional → biomarkers → long-term)

• 19:47–23:04 — Practical method: define outcome, simplify metrics, fix terrain, add one lever, evaluate humbly, build stack

• 23:04–26:59 — Personas + closing thesis: biohacking works when it respects biology, evidence, dose, context, and constraints

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

The “Second Hit” After Concussion: How Methylene Blue May Protect the Brain’s Mitochondria

Traumatic brain injury isn’t just the impact, it’s the secondary injury cascade that follows: swelling, inflammation, oxidative overload, mitochondrial dysfunction, and immune activation that won’t shut off. In this Deep Dive, Dr. Mike Belkowski unpacks a mouse-model study where methylene blue was associated with better outcomes across multiple layers of that cascade: reduced early brain edema, improved acute neurological scores, smaller lesion volume over time, and greater neuronal survival.

Then we go deeper into the “Energy Code” mechanisms: microglial activation (the brain’s immune cleanup crew that can become chronically destructive), autophagy (cellular cleanup that clears damaged parts after trauma), and why damaged mitochondria can lock the brain into an inflammation ↔ mitochondrial damage loop. The big message: brain injury is an energy crisis, and strategies that stabilize mitochondrial function, support cleanup, and improve resolution may shift the recovery trajectory.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation

-

Key Quotes From Dr. Mike:

“Pressure inside the skull is like trying to run a high-performance engine while someone steps on the fuel line.”

“If microglia stay activated too long, they can become the thing that keeps the injury going.”

“Damaged mitochondria drive inflammation. Inflammation drives more mitochondrial damage.”

“This is why a mitochondrial-first model of brain resilience makes sense.”

“The goal isn’t to eliminate ROS—the goal is to prevent chronic overload and restore redox balance.”

-

Key points

• TBI damage expands through secondary injury (swelling, inflammation, oxidative stress, mitochondrial failure, BBB disruption).

• Swelling = pressure, pressure compromises blood flow/oxygen → brain energy crisis.

• In a mouse TBI model, methylene blue was associated with:

  • Less edema ~24h

  • Better neuro scores at 24h and 72h

  • Smaller lesion volume at 24h, 72h, and 14d

  • More neuronal survival early

• Microglia: essential responders, but chronic activation becomes collateral damage.

• Methylene blue was associated with reduced microglial activation at 72h and 14d.

• Autophagy = cellular maintenance; after injury, cleanup becomes survival.

• Study showed markers consistent with higher autophagy activity acutely with methylene blue.

• Damaged mitochondria amplify inflammation; inflammation further damages mitochondria → self-perpetuating loop.

• “Mitochondria-first” recovery lens: improve energy efficiency, reduce oxidative overload, support resolution.

• Stack mindset: light (PBM), sleep/circadian timing, nutrient status shape recovery capacity.

• Antioxidants aren’t “more is better”; goal is redox balance, not zero ROS.

-

Episode timeline

• 0:19–1:42 — Frame: TBI + methylene blue; secondary injury explained

• 1:42–3:40 — Outcomes: edema ↓, neuro scores ↑, lesion volume ↓, neuronal survival ↑

• 3:40–4:59 — Microglia: acute defense vs chronic damage; MB association with reduced activation

• 4:59–6:20 — Autophagy as cleanup; MB association with increased acute cleanup signaling

• 6:20–7:40 — Why mitochondria matter: ROS/inflammation loop; MB as mitochondrial efficiency concept

• 7:40–9:18 — Stack thinking: PBM/light + resolution framing + fundamentals (sleep/circadian/nutrients)

• 9:18–11:13 — Redox realism + big takeaway: TBI = energy crisis; aging parallels; close

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

Alzheimer’s Isn’t Just Plaques — It’s a Mitophagy Breakdown (Brain Energy Failure Explained)

Alzheimer’s is usually framed as plaques and tangles—but this Deep Dive goes upstream: mitochondrial failure and impaired mitophagy. Dr. Mike Belkowski breaks down mitophagy as the brain’s selective mitochondrial cleanup system—and why neurons are uniquely vulnerable when damaged mitochondria can’t be transported, tagged, and fully degraded.

You’ll learn how mitophagy appears impaired across multiple steps in Alzheimer’s (initiation, recruitment, transport, lysosomal fusion, and degradation), how hallmark factors like tau, amyloid-beta, APP fragments (APP-CTFs), and APOE4 can jam the machinery, and why the real therapeutic target may be mitophagy flux—not just turning the process “on,” but ensuring cleanup completes from start to finish. The episode closes with a systems-based framework for breaking the loop: reduce chronic stressors, support mitochondrial signaling, and prioritize lifestyle levers that promote mitochondrial quality control.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches

-

Key Quotes From Dr. Mike:

“Alzheimer’s isn’t just plaques and tangles — it’s also a story about energy failure.”

“Mitophagy is selective mitochondrial cleanup.”

“If you don’t remove broken mitochondria, they don’t sit quietly—they leak.”

“You can’t just ask, ‘Is mitophagy turned on?’ You have to ask, ‘Is mitophagy completing?’”

“Damaged mitochondria accumulate → more oxidative stress → more energy failure → worse cleanup.”

“The future isn’t just ‘turn on mitophagy.’ It’s support mitophagy flux from start to finish.”

-

Key points

• Mitophagy = selective mitochondrial cleanup (tag → wrap → lysosome → recycle).

• In neurons, cleanup is harder: lysosomes are mainly in the soma, so damaged mitochondria in axons must be transported back.

• In Alzheimer’s, damaged mitochondria accumulate, especially near synapses → ROS, calcium disruption, inflammation, ATP loss.

• Evidence summarized: Alzheimer’s brains show reduced mitophagy signatures + structurally damaged mitochondria (cristae disruption, low ATP).

• Mitophagy impairment can occur at multiple failure points (initiation → LC3 recruitment → AMPK/ULK1/TBK1 signaling → lysosomal fusion).

• Key principle: initiation ≠ completion; if lysosomal fusion fails, you get “garbage bags with no pickup.”

• Transport deficits (incl. DISC1-related trafficking roles) can worsen mitochondrial congestion.

• Alzheimer’s proteins can jam mitophagy: tau (PINK1/Parkin interference), amyloid-beta (context-dependent; flux often blocked downstream).

• APP-CTFs may correlate strongly with mitophagy marker changes and may disrupt mitochondria-associated membranes (MAMs).

• APOE4 links to autophagy/lysosomal dysfunction, a major bottleneck for clearance.

• Therapeutic direction: not just “boost mitophagy,” but support mitophagy flux + lysosomal capacity + brain penetration.

• Biggest levers aren’t only compounds—exercise, fasting-style metabolic stress, rhythm/sleep are core mitophagy signals; chronic stressors crush it.

-

Episode timeline

• 0:19–1:45 — Frame: Alzheimer’s as energy + cleanup failure; define mitophagy

• 1:45–2:45 — Neuron logistics: soma lysosomes, axonal transport, synaptic vulnerability

• 2:45–4:20 — Evidence: impaired mitophagy markers + damaged mitochondria; “completion vs initiation”

• 4:20–5:15 — Transport issues (DISC1) and multi-step failure points

• 5:15–8:15 — Mapping AD factors to mitophagy failure: tau, amyloid, APP-CTFs/MAMs, APOE4

• 8:15–9:40 — The vicious loop (mitochondria ↔ ROS ↔ inflammation ↔ clearance failure)

• 9:40–11:35 — Breaking the loop: flux-first strategy; compounds under investigation; bottlenecks

• 11:35–14:10 — Lifestyle levers + Biolite “mitochondria stack” framing; systems-based takeaway

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

Your Mitochondria Are Listening: The Gut–EV–Mitochondria Axis That Controls Aging, Energy & Fertility

Mitochondria aren’t isolated “batteries”... they’re sensors responding to your light exposure, diet, sleep, stress, inflammation, toxins, and microbiome. In this Deep Dive, Dr. Mike Belkowski unpacks a powerful emerging framework: the gut–extracellular vesicle–mitochondria axis—how microbial metabolites and tiny biological “delivery packages” (EVs) can travel through the body and influence mitochondrial efficiency, oxidative stress, inflammation, senescence, and tissue resilience.

Using reproductive aging as the case study (one of the earliest mirrors of biological age), we zoom out to show why this axis likely impacts systemic aging, brain health, metabolic health, recovery, and longevity. You’ll learn how signals like urolithin A, butyrate, indole compounds, and polyphenol metabolites interact with mitochondrial quality control; and why the real goal isn’t “eliminating ROS,” but restoring redox intelligence and breaking the chronic loops that accelerate aging.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

The Gut–Extracellular Vesicle–Mitochondria Axis in Reproductive Aging: Antioxidant and Anti-Senescence Mechanisms

-

Key Quotes From Dr. Mike:

“If you’re not feeding your microbiome, you’re missing a major upstream lever for mitochondrial health.”

“Mitophagy is a clean-up process that helps maintain mitochondrial quality.”

“ROS damages mitochondria. Damaged mitochondria produce more ROS.”

“Mitochondria aren’t just energy—mitochondria are aging.”

“Circadian disruption is a mitochondrial toxin.”

-

Key points

• Mitochondria are sensors, not just ATP producers—your inputs are signals.

• The gut–EV–mitochondria axis: microbiome metabolites + EV cargo influence mitochondrial function system-wide.

• Reproductive aging is mitochondrial aging: egg/sperm quality depends on energy, membranes, redox, and QC.

• ROS isn’t “bad”—it’s normal signaling; damage happens when ROS > antioxidant capacity.

• The microbiome produces metabolites that shape inflammation, redox control, biogenesis, and mitophagy.

• Urolithin A = mitophagy / mitochondrial housekeeping signal (microbiome-dependent).

• Butyrate (SCFA) = gut barrier + inflammation modulation + resilience/biogenesis signaling.

• EVs are delivery packages that can carry enzymes + regulatory signals; cargo quality matters.

• Chronic stress/inflammation can shift EV cargo toward broadcasting dysfunction.

• Senescence loop: mitochondrial dysfunction ↔ ROS ↔ inflammation ↔ senescence (self-amplifying).

• Practical framing: diet, fiber, polyphenols, sleep timing, light, training = information mitochondria respond to.

• Longevity strategy = break loops and build resilient systems, not symptom-chasing.

-

Episode timeline

• 0:19–2:25 — Why mitochondria are sensors; intro to the gut–EV–mitochondria axis

• 2:25–4:20 — Reproductive aging as a mitochondrial story; ROS as “controlled fire”

• 4:20–10:18 — Microbiome metabolites: urolithin A, butyrate, indoles, polyphenol metabolites; “diet = information”

• 10:18–13:46 — What EVs are; protective vs pro-inflammatory cargo; broadcasting dysfunction

• 13:46–14:34 — Reproductive aging as a window into systemic aging

• 14:34–19:32 — Biolite “mitochondria stack” lens: light, MB, hydrogen, DDW, circadian rhythm (systems approach)

• 19:32–21:28 — Antioxidants misconception; restoring redox intelligence vs blunting adaptation

• 21:28–24:09 — Big synthesis: breaking loops + “your mitochondria are listening”

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

Stop Borrowing Energy From Tomorrow: The Science of Ergothioneine + Ginseng + Rhodiola

Most “energy” products are just caffeine in disguise — a short-term loan with a brutal crash. In this Deep Dive, we go beyond stimulation and into real cellular energy by decoding a three-compound “energy code” found inside BioElixir MIND: Ergothioneine (EGT), Panax ginseng, and Rhodiola rosea.

You’ll learn why EGT is called a “longevity vitamin” (and how it outperforms major antioxidants in lab testing), how the body uses a dedicated transporter (OCTN1) to deliver it into high-risk tissues like the eyes and brain, and why EGT’s stability matters in the real world. Then we shift to Panax ginseng and its surprising links to telomere length and a more youthful NAD⁺/NADH ratio, plus human-reported improvements in sleep, fatigue, cognition, and sexual health. Finally, we break down Rhodiola as a true adaptogen — less “stimulant,” more thermostat — supporting stress resilience, mood, and focus while keeping the cardiovascular system steady.

If you’re tired of “wash the windshield” advice, this is the episode that talks about fixing the engine.

(Educational content only, not medical advice.)

-

Articles Discussed in Episode:

Ergothioneine: Evaluation of a Novel Antioxidant for Targeting Ocular Oxidative Stress

Panax ginseng Meyer supplementation and potential associations with telomere length and NAD+/NADH ratio in middle-aged adults: An exploratory study

Phenolic Compounds of Rhodiola rosea L. as the Potential Alternative Therapy in the Treatment of Chronic Diseases

-

Key Quotes From Dr. Mike:

“Most ‘energy’ isn’t energy — it’s borrowing from tomorrow.”

“EGT isn’t just strong in a test tube — your body built a VIP entrance specifically to pull it into cells.”

“EGT doesn’t just clean up oxidative stress — it helps prevent new damage from forming.”

“Ginseng didn’t just change how people felt — it moved biomarkers tied to biological aging.”

“Rhodiola isn’t a gas pedal. It’s cruise control.”

“Shield, repair, resilience — that’s the real energy code.”

-

Key points

• Caffeine ≠ energy: it’s “borrowing energy from tomorrow” with interest.

• The “Energy Trinity”: EGT (shield) + Panax ginseng (restore) + Rhodiola (resilience).

• EGT’s standout potency: extreme free-radical scavenging in standardized assays vs common antioxidants.

• EGT targets the worst offenders: especially hydroxyl radicals and hypochlorous acid.

• Metal chelation matters: EGT binds free iron/copper to reduce radical formation (prevention, not just cleanup).

• Bioavailability solved: the body has a dedicated EGT transporter (OCTN1)—a built-in “VIP door.”

• High-value delivery zones: OCTN1 is highly expressed in the retina/cornea and brain.

• Real penetration evidence: ocular model shows EGT reaching the back of the eye quickly after topical use.

• EGT is unusually stable: retains potency under heat/humidity—rare for antioxidants.

• Ginseng & aging markers: associated with telomere elongation and improved NAD⁺/NADH ratio in humans.

• Rhodiola = thermostat: improves stress resilience and mental stamina without the jittery stimulant profile.

• Timing matters: Rhodiola is best earlier in the day to avoid sleep disruption.

-

Episode timeline

• 0:19–1:40 – Why modern “energy” is mostly caffeine + maintenance-level advice

• 1:40–3:45 – The thesis: 3 molecules that unlock cellular energy (and how they map to BioElixir MIND)

• 4:18–17:35 – Ergothioneine (EGT): potency, what it targets, metal chelation, OCTN1 “VIP transporter,” ocular penetration, and stability

• 17:38–26:15 – Panax ginseng: telomeres, NAD⁺/NADH ratio, and reported improvements (sleep, fatigue, cognition, sexual health)

• 26:22–32:20 – Rhodiola rosea: adaptogen definition, stress resilience, neurotransmitter support, calm-focus effect, best timing

• 32:57–end – The synthesis: EGT = shield, ginseng = restoration, rhodiola = resilience

-

⚡ BioElixir MIND: Shield • Restore • Resilience ⚡

BioElixir MIND is built for real cellular energy, not a jittery stimulant spike. Inspired by today’s Deep Dive, it combines ergothioneine (EGT) to help defend high-demand tissues from oxidative stress, Panax ginseng to support the body’s energy and aging architecture (think NAD⁺ balance and cellular renewal), and Rhodiola rosea for calm, steady resilience under stress. 

 

BioElixir MIND also incorporates Alpha-GPC + Citicoline, PQQ, Acetyl-L-Carnitine  and Shilajit. The result? Smooth cognitive performance without the harsh spikes and crashes.

 

If coffee feels like a loan with interest, MIND is the upgrade: shield the system, restore the engine, and stay sharp without the crash.

 

Clarity isn’t accidental. It’s engineered.

 

Save 15% off your order of BioElixir MIND!

 

Discount code: MIND15

 

Expires on 3/4, midnight PST

 

*Must use "Single" quantity option; code will not work for 2-, 4- or 10-pack quantity options.

 

Shop BioElixir MIND!

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

Did Your Dad Contribute to Your Mitochondria? The “Spare Tire” Theory That Could Rewrite Biology

In this Energy Code Deep Dive, Dr. Mike Belkowski and co-host Don Bailey unpack a 2025 review in Mitochondrion that challenges one of biology’s most entrenched rules: the idea that mitochondrial DNA is inherited only from the mother.

For decades, paternal mitochondria were considered disposable “damaged goods” — actively destroyed by the egg through highly conserved cellular cleanup systems. But this episode explores mounting evidence that the rule may be more flexible than we thought, especially under crisis conditions.

The hosts break down:

• why biology usually enforces maternal-only mitochondrial inheritance,

• how paternal mitochondria are normally eliminated,

• the controversy over “paternal leakage” and human case reports,

• why NUMTs (nuclear mitochondrial DNA fossils) created years of scientific confusion,

• and the breakthrough 2024 fruit fly study that provided functional proof of paternal mitochondrial rescue.

Their central takeaway is a powerful new idea: paternal mitochondrial inheritance may not be random leakage at all — it may be a built-in evolutionary fail-safe, a cellular “spare tire” activated only when the mother’s mitochondria fail.

This episode reframes biology not as a system of rigid laws, but as a dynamic intelligence built for survival.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Research progress on paternal mitochondrial inheritance: An overview

-

Key Quotes From Dr. Mike:

“This idea of maternal inheritance has been treated like an absolute law.”

“The old rule was simple: dad gives nuclear DNA, mom gives the mitochondria. This paper says the story may be more flexible than that.”

“The cell doesn’t reject paternal mitochondria just because they’re from dad — it rejects them because mixing mitochondrial code can create chaos.”

“The ‘spare tire’ theory is simple: a damaged backup is still better than no energy at all.”

“The cell may be willing to break its own inheritance rules if that’s what it takes to keep ATP flowing and keep life alive.”

-

Key points

1. The episode challenges a core biology rule: mtDNA may not be strictly maternal in all cases.

2. A 2025 review suggests paternal mtDNA inheritance can occur in crisis conditions.

3. This matters for disease diagnosis, evolution, and metabolic biology.

4. Maternal-only inheritance helps avoid heteroplasmy (conflicting mitochondrial DNA populations).

5. Eggs dominate mtDNA by numbers (huge mtDNA load vs. very few in sperm).

6. Sperm mitochondria are essential for motility but often arrive oxidatively stressed (“damaged goods”).

7. Cells actively destroy paternal mitochondria using robust cleanup pathways (autophagy, ubiquitination, etc.).

8. Rare “paternal leakage” signals were seen for years but often dismissed as anomalies.

9. A 2002 human case showed paternal mtDNA can persist and contribute to disease.

10. The 2018 Luo study reignited the field by reporting biparental inheritance in multiple families.

11. NUMTs complicated the debate because they can mimic mtDNA in standard sequencing.

12. A 2024 fruit fly study provided functional proof of paternal mitochondrial rescue.

13. The key breakthrough: offspring survived despite failed maternal mitochondria, implying functional paternal mitochondria.

14. This supports a “Spare Tire Theory” — paternal mitochondria may act as an emergency backup.

15. The cell may accept heteroplasmy risk to avoid total energy failure.

16. Surviving offspring showed restored mitochondrial function (including Complex I activity).

17. The signaling mechanism is still unknown (how the egg decides to spare paternal mitochondria).

18. This could reshape mitochondrial disease treatment by activating a natural rescue pathway.

19. The idea is to trigger an existing backup system, not invent a new one.

20. Big takeaway: biology may be full of hidden “backup plans” that activate under stress.

-

Episode timeline 

• 0:19–1:20 — Intro + premise: a “biology law” may be breaking (maternal-only mitochondrial inheritance).

• 1:20–3:12 — Why it matters: impacts mitochondrial disease, evolution, and metabolic biology.

• 3:12–5:03 — Standard dogma: mtDNA is maternal to avoid heteroplasmy; egg vs. sperm mtDNA numbers.

• 5:03–6:30 — Why sperm still carry mitochondria: needed for motility, but often oxidatively damaged.

• 6:30–8:55 — “Demolition crew” mechanisms: how cells destroy paternal mitochondria (autophagy, ubiquitination, etc.).

• 8:55–10:31 — Early anomalies: paternal leakage and the 2002 human case of paternal mtDNA persistence.

• 10:31–13:21 — 2018 Luo study + controversy: biparental inheritance claim vs. NUMT sequencing confounders.

• 13:21–15:33 — 2024 fruit fly breakthrough: functional proof paternal mitochondria can rescue offspring.

• 15:33–17:34 — “Spare Tire Theory”: paternal mitochondria as an emergency backup when maternal mitochondria fail.

• 17:34–18:21 — Open question: how the egg senses failure and pauses paternal mtDNA destruction.

• 18:21–20:19 — Clinical implications: possible future mitochondrial disease therapies via rescue-pathway activation.

• 20:19–21:43 — Big-picture synthesis: biology is adaptive, not rigid; paternal mtDNA may be a lifesaving fail-safe.

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

Cancer’s Hidden Engine Room: How Tumors Hijack Mitochondria to Grow, Spread, and Survive

In this Energy Code Deep Dive, Dr. Mike Belkowski and co-host Don Bailey unpack a striking 2025 paper by Liu and colleagues on gastrointestinal cancers (especially gastric and colorectal tumors) and why we may be looking in the wrong place for answers.

Instead of focusing only on DNA mutations, this episode explores the mitochondria as the cell’s decision-makers; the organelles that help determine whether a cell grows, rests, or dies. The hosts break down the paper’s framework of mitochondrial quality control (MQC) into three core pillars: biogenesis (make), dynamics (shape), and mitophagy(break/recycle).

They explain how tumors hijack these systems to fuel growth, metastasis, and drug resistance — and how therapies may work by disrupting the cancer cell’s energy code, not just damaging DNA. The conversation also covers PGC-1α, fission/fusion proteins, mitophagy under hypoxia, chemo resistance, and a fascinating (and very weird) malaria-related finding that reinforces the core concept.

The big takeaway: cancer may be less about a broken blueprint and more about a corrupted energy system.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

The role of mitochondrial biogenesis, mitochondrial dynamics and mitophagy in gastrointestinal tumors

-

Key Quotes From Dr. Mike:

“There is no one-size-fits-all energy code.”

“Cancer isn’t just a genetic accident, it’s a fundamental corruption of how the cell handles energy.”

“The shape of the mitochondria literally determines how well chemotherapy works.”

“Cancer operates in a Goldilocks zone.”

“Proton beam therapy… also works by hacking the energy code.”

-

Key points

1. GI cancers remain a massive global burden
   • The episode opens with sobering numbers: millions of new GI tumor cases and deaths annually.
   • Focus is specifically on gastric and colorectal cancers.
2. The paper shifts focus from DNA to mitochondria
   • Modern oncology often centers on mutations.
   • This review argues mitochondria are not just “batteries” — they are decision-makers controlling cell fate.
3. Cancer is framed as a corruption of the “energy code”
   • The hosts describe tumors as hijacking mitochondrial decision-making.
   • Cancer rewrites the systems that regulate growth, dormancy, and apoptosis.
4. Mitochondrial Quality Control (MQC) is the core framework
   • The paper’s model has three pillars:
     • Biogenesis (making mitochondria)
     • Dynamics (shaping mitochondria via fission/fusion)
     • Mitophagy (recycling damaged mitochondria)
   • The hosts summarize this as: “make, shape, and break.”
5. Pillar 1: Biogenesis fuels tumor growth
   • Tumors need energy to expand, so they ramp up mitochondrial production.
   • PGC-1α is presented as the key “foreman” regulating this process.
6. Cancer operates in a biogenesis Goldilocks zone
   • Some biogenesis is necessary for tumor growth.
   • But too much PGC-1α can push cells into apoptosis (cell death), making it a fragile balance.
7. Excess biogenesis can become toxic to cancer
   • Overproduction of mitochondria can trigger death pathways (via BAX/Bak-type mitochondrial apoptosis signaling, as described in the transcript).
   • This creates a therapeutic opportunity: push tumor energy systems beyond their tolerance.
8. Tumors actively silence genes that would normalize metabolism
   • The episode describes a gastric cancer example where a gene is silenced/methylated to preserve the tumor’s metabolic advantage (including the Warburg effect dynamics).
9. Proton beam therapy may work partly by disrupting mitochondrial balance
   • The hosts note a non-obvious mechanism:
   • Beyond DNA damage, proton therapy may force excess mitochondrial biogenesis and push tumors into collapse.
10. Pillar 2: Mitochondrial dynamics = shape-shifting for survival
    • Mitochondria constantly undergo:
      • Fission (splitting)
      • Fusion (merging)
    • This is described with a “lava lamp” analogy.
11. Fission supports metastasis
    • Fragmented mitochondria are easier to move within the cell.
    • Cancer uses this to bring energy to the “leading edge” during invasion and spread.
12. Fusion/fission proteins are strategic levers
    • The episode highlights:
      • DRP1 (fission)
      • MFN1, MFN2, OPA1 (fusion)
    • Aggressive tumors exploit these pathways to support mobility and growth.
13. Chemo resistance is partly an energy-grid strategy
    • In Adriamycin-resistant cells, tumors increase fission and reduce fusion.
    • By breaking mitochondrial networks into “islands,” they quarantine damage and survive drug stress.
14. Mitochondrial shape influences chemotherapy effectiveness
    • The episode emphasizes that mitochondrial structure is not cosmetic — it changes treatment response.
    • The “energy grid” layout can determine whether toxicity spreads or is contained.
15. Pillar 3: Mitophagy = recycling damaged engines
    • Mitophagy is a mitochondria-specific form of autophagy.
    • In healthy cells, it’s protective quality control (e.g., PINK1/Parkin pathway).
16. Tumors weaponize mitophagy under stress
    • In nutrient-poor or hypoxic tumor cores, cancer ramps up mitophagy to recycle parts and survive.
    • The recycling center becomes a survival grocery store.
17. Hypoxia/mitophagy dysregulation increases ROS stress
    • The episode discusses loss of mitophagy regulators (e.g., BNIP3 in gastric cancer contexts), which alters ROS and tumor behavior.
18. The Plasmodium (malaria parasite) finding reinforces the concept
    • A surprising section describes how Plasmodium infection can suppress colon tumor growth.
    • Not as a treatment idea, but as proof that disrupting mitochondrial biogenesis/mitophagy can collapse tumor survival systems.
19. Drug resistance examples show tumors actively re-code metabolism
    • 5-FU resistance: tumors increase PGC-1α to power through treatment.
    • Oxaliplatin resistance: tumors use exosome-mediated changes and oxidative phosphorylation support.
20. Natural compounds may act as mitochondrial “signal jammers”
    • The hosts discuss compounds highlighted in the paper:
      • Resveratrol (supports healthier mitochondrial biogenesis)
      • 8-gingerol / ginger compounds (push mitophagy/apoptosis pathways)
      • Xanthohumol (from hops; anti-proliferative effects)
      • Metformin (preserves normal structure and may inhibit tumor fission)

21. Metformin is framed as anti-metastatic via dynamics
    • By inhibiting fission, metformin may keep tumor mitochondria from fragmenting.
    • “Heavy engines” are harder to mobilize for metastasis.
22. The future is targeted energy-code therapy, not just poisoning cells
    • The episode contrasts blunt-force cytotoxic therapy with precision mitochondrial disruption.
    • The goal: break the tumor’s energy balancing system.
23. There is no universal mitochondrial strategy across cancers
    • The hosts stress a key warning: the mitochondrial “code” is personalized.
    • What helps one tumor survive may kill another.
24. Precision oncology will require mapping mitochondrial behavior
    • Future treatment may need profiling of tumor energy patterns:
      • fission-dominant vs fusion-dominant
      • biogenesis-sensitive vs biogenesis-dependent
      • mitophagy-dependent states

25. Final philosophical takeaway: cancer may awaken an ancient survival program
    • The episode closes with an evolutionary lens:
    • Since mitochondria originated from ancient bacteria, tumors may be exploiting deeply conserved survival behaviors.

-

Episode timeline 

0:00–1:02 — Opening: the GI cancer burden and the central premise

The episode opens with global GI cancer incidence/death numbers and introduces the 2025 Liu paper’s challenge to DNA-only cancer thinking.

1:02–2:16 — Mitochondria as decision makers

The hosts reframe mitochondria as active regulators of cell fate (growth, dormancy, death), not just batteries.

2:16–3:13 — Mitochondrial Quality Control (MQC): the 3 pillars

They introduce the “factory” analogy and the three MQC pillars:

• Biogenesis
• Dynamics
• Mitophagy

(“Make, shape, and break.”)

3:13–6:45 — Pillar 1: Biogenesis and the PGC-1α Goldilocks zone

• How tumors ramp up mitochondrial production
• PGC-1α as the “foreman”
• Too much biogenesis can trigger apoptosis
• Tumor methylation/silencing strategies
• Proton beam therapy as energy-code disruption

6:45–10:50 — Pillar 2: Dynamics (fission/fusion) and metastasis/drug resistance

• “Lava lamp” analogy for fission vs fusion
• DRP1, MFN1/2, OPA1 roles
• Why fragmented mitochondria help invasion
• Adriamycin resistance and mitochondrial “islanding”
• How mitochondrial shape affects chemo response

10:50–14:00 — Pillar 3: Mitophagy and tumor survival under stress

• Mitophagy as mitochondrial-specific autophagy
• PINK1/Parkin pathway basics
• Tumors using mitophagy to survive nutrient-poor cores
• Hypoxia, ROS, and regulator changes
• Plasmodium/malaria finding as proof-of-concept for breaking tumor energy systems

14:00–17:42 — Therapeutic implications: resistance + natural compounds + metformin

• 5-FU and oxaliplatin resistance as mitochondrial adaptation
• Resveratrol, ginger compounds, xanthohumol
• Metformin’s role in protecting normal mitochondria while inhibiting tumor fission
• Shift toward targeting machinery, not just poisoning cells

17:42–18:53 — Personalization warning: no universal energy code

• Different tumors respond differently to fission/fusion/biogenesis
• Precision oncology will require tumor-specific mitochondrial profiling

18:53–19:58 — Closing thought: the ancient mitochondrial survival program

• Endosymbiotic theory
• Is cancer reawakening an ancient bacterial survival strategy?
• Final takeaway: ask what’s happening in the mitochondria

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

Aging Is a Civil War: How Your Telomeres and Mitochondria Fight Each Other

In this Energy Code Deep Dive, Dr. Mike Belkowski and Don Bailey unpack a powerful new model of aging: it’s not just “wear and tear” — it’s a communication breakdown between two core systems in the cell: telomeres (the clock) and mitochondria (the engine).

Based on a recent review in the International Journal of Molecular Sciences, this episode explores how these two longevity pillars are deeply linked through oxidative stress, telomerase (TERT), and the p53 pathway. The hosts explain how damaged telomeres can shut down mitochondrial biogenesis, how dysfunctional mitochondria accelerate telomere erosion, and why this feedback loop drives cellular senescence, immune aging, and tissue decline.

They also dive into the “TERT commuting” phenomenon (telomerase moving into mitochondria), the role of ROS in damaging guanine-rich telomeres, the rise of “zombie cells,” extracellular citrate as a possible future aging biomarker, and the biggest twist of all: why sperm cells seem to bend the rules of aging — and how cancer hijacks the same system.

This is a big-picture episode about aging, metabolism, and longevity strategy: if you want to protect your DNA, you have to protect your mitochondria.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Exploring the Link Between Telomeres and Mitochondria: Mechanisms and Implications in Different Cell Types

-

Key Quotes From Dr. Mike:

“Aging isn’t just parts breaking down in isolation. It’s a communication breakdown.”

“The clock breaks the engine, and the engine breaks the clock.”

“TERT isn’t just for making you live longer by lengthening telomeres… it’s trying to keep the power on too.”

“Biology prioritizes safety over repair.”

“If you wanna protect your DNA, your telomeres — you have to protect your mitochondria.”

-

Key points

1. Aging is framed as a communication breakdown, not just mechanical wear
   • The episode challenges the “slow breakdown” model of aging.
   • Instead, aging is described as a cellular civil war between telomeres and mitochondria.
2. The paper links two traditionally separate longevity domains
   • Telomere biology and mitochondrial biology are often studied independently.
   • This review argues they are part of the same core aging system.
3. Telomeres are the cell’s “clock”
   • Telomeres protect chromosome ends like shoelace tips.
   • They shorten with cell division (Hayflick limit), eventually triggering senescence.
4. Mitochondria are the cell’s “engine”
   • They generate ATP but also produce ROS (reactive oxygen species) as metabolic exhaust.
   • Small ROS = signaling; too much ROS = oxidative damage.
5. TERT isn’t only nuclear — it also goes into mitochondria
   • A major insight from the episode: ~10–20% of TERT can localize to mitochondria.
   • Under mild stress, the cell sends TERT to mitochondria as a protective shield against ROS damage.
6. The “axis of aging”: short telomeres trigger a p53 shutdown cascade
   • Critically short/damaged telomeres activate DNA damage response (DDR).
   • This activates p53, which prioritizes safety (anti-cancer control) over repair.
7. p53 suppresses mitochondrial renewal
   • p53 represses PGC-1α / PGC-1β (mitochondrial biogenesis regulators).
   • It also suppresses SIRT1, worsening metabolic decline.
   • The result: fewer new mitochondria, failing old mitochondria, and cellular senescence.
8. Mitochondria can “break the clock” too
   • Dysfunctional mitochondria leak excess ROS.
   • ROS preferentially damages guanine-rich telomeric DNA, accelerating telomere shortening.
9. Why telomeres are especially vulnerable to oxidative stress
   • Telomeres are rich in guanine (G), which has low redox potential (“rusts easily”).
   • ROS oxidizes guanine into 8-oxo-dG, impairing replication and telomere integrity.
10. This creates a vicious cycle (death spiral)
    • Mitochondrial dysfunction → ROS → telomere damage → p53 activation → mitochondrial shutdown.
    • The cell becomes trapped in senescence.
11. Immune aging is a real-world example of this loop
    • T cells need massive ATP to proliferate during infection.
    • In older adults, shortened telomeres and p53 signaling impair mitochondrial function.
    • This contributes to immunosenescence (weaker immune response with age).
12. Skin aging also reflects the telomere-mitochondria link
    • Fibroblasts under UV/oxidative stress show faster telomere shortening.
    • Even without rapid division, poor metabolism can age tissue faster.
13. PBM/red light therapy is framed as a “genome protection” strategy
    • The hosts connect photobiomodulation (PBM) to improved mitochondrial efficiency and lower ROS.
    • Their argument: better mitochondrial function may help protect telomeres indirectly by reducing oxidative stress.
14. Senescent cells undergo metabolic reprogramming
    • They shift from oxidative phosphorylation (OXPHOS) to glycolysis.
    • This is less efficient and leads to metabolite buildup, especially citrate.
15. Extracellular citrate may be a future aging biomarker
    • Senescent cells can dump citrate outside the cell (“extracellular senescence metabolism”).
    • The episode suggests this “cellular trash” could become a real-time aging readout.
16. p53 also fragments mitochondria via PRKN2 and fusion loss
    • The review describes p53-linked signaling degrading fusion proteins MFN1/MFN2.
    • Mitochondria fragment, become dysfunctional, and worsen metabolic breakdown.
17. The “sperm paradox” breaks the aging rules
    • Sperm telomeres are longer than somatic cells.
    • In men, sperm telomeres can actually lengthen with age (with caveats).
18. Mild stress in sperm may activate telomerase
    • Unlike somatic cells, mild oxidative stress in sperm may stimulate TERT activity.
    • The hosts frame this as an evolutionary “extra armor” mechanism for offspring.
19. But too much stress still harms sperm
    • Excess ROS can still fragment sperm DNA and impair fertility.
    • The benefit appears to be a narrow Goldilocks zone.
20. Cancer is presented as the “master hacker” of the energy code
    • Cancer reactivates TERT (immortality enzyme) and often disables p53.
    • It exploits glycolysis (Warburg effect) and metabolic conditions like high glucose.
21. Core takeaway: protect the engine to protect the clock
    • Telomere health and mitochondrial health are inseparable.
    • Longevity strategy = reduce unnecessary oxidative stress and support mitochondrial function.

-

Episode timeline 

0:19–1:28 — Intro: aging as a communication breakdown

The hosts challenge the “wear and tear” model of aging and introduce a new framework: aging as a cellular communication failure.

1:28–2:52 — The core thesis of the paper

They introduce the review’s central idea: telomeres and mitochondria are not separate aging systems — they are deeply linked.

2:52–4:23 — Character setup: the clock and the engine

• Telomeres = clock
• Mitochondria = engine
• ROS = exhaust

4:23–6:53 — TERT localization: telomerase in mitochondria

A major insight: TERT (telomerase reverse transcriptase) can relocate to mitochondria and help protect mitochondrial DNA under mild stress.

6:53–10:32 — The aging axis: how the clock breaks the engine

• Telomere damage activates DDR
• DDR activates p53
• p53 suppresses PGC-1α/β and SIRT1
• Mitochondrial biogenesis declines
• Cells become senescent (“zombie” cells)

10:32–12:43 — The reverse attack: how the engine breaks the clock

• Dysfunctional mitochondria leak ROS
• ROS attacks guanine-rich telomeric DNA
• Oxidative lesions (8-oxo-dG) impair replication
• Telomeres shorten faster

12:53–14:15 — Real-world consequence: immune aging (T cells)

The hosts explain immunosenescence through the telomere–mitochondria loop, especially in energy-demanding T cells.

14:23–15:19 — Skin aging and fibroblasts

UV-induced oxidative stress, impaired metabolism, and accelerated telomere shortening in fibroblasts tie the mechanism to visible aging.

15:19–16:18 — PBM / red light therapy connection

They connect photobiomodulation to mitochondrial support and oxidative stress reduction, framing it as systemic support for telomere protection.

16:24–18:45 — Senescent metabolism and extracellular citrate

• Senescent cells shift to glycolysis
• Citrate accumulates and is exported
• p53/PRKN2 signaling fragments mitochondria via MFN1/MFN2 loss
• Extracellular citrate is proposed as a potential aging biomarker

18:58–22:17 — The sperm paradox

• Sperm telomeres are long and may lengthen with paternal age
• Mild oxidative stress may activate telomerase in sperm
• Evolutionary rationale and fertility caveats
• Goldilocks stress zone + mention of CIC transporter

22:22–24:13 — Cancer as an energy-code hacker

• Cancer reactivates TERT
• Disables p53
• Uses glycolysis (Warburg effect)
• High glucose can help sustain the hacked growth program

24:24–25:36 — Big-picture takeaway

• You can’t treat telomeres and mitochondria separately
• Protect mitochondria to protect telomeres
• “Maintenance over repair”

25:45–26:49 — Provocative closing thought

• Future aging diagnostics may track extracellular “exhaust” (like citrate), not just DNA clocks
• Can senescent metabolism be repaired instead of merely eliminated?

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook

Fertility After 40: Can Red & Near-Infrared Light “Recharge” Egg Quality?

In this Energy Code Deep Dive, Dr. Mike Belkowski and Don Bailey challenge one of the biggest assumptions in reproductive health: that age-related infertility is only about “running out of time.” Instead, they explore a bold idea from a 2024 case series—what if the deeper issue is running out of cellular energy?

This episode unpacks a study on multi-wavelength red and near-infrared photobiomodulation (PBM) used in women ages 40–43 with difficult fertility histories, including failed IVF cycles and miscarriages. The hosts explain why the egg cell is the most mitochondria-dense cell in the body, how mitochondrial decline affects egg quality and chromosomal accuracy, and how PBM may help by boosting ATP production, improving blood flow, reducing inflammation, and supporting the reproductive environment.

They also break down the surprisingly systemic treatment protocol (abdomen, lower back, neck, lymph, gut), why multi-wavelength light matters for tissue depth, and the three case outcomes that make this paper so compelling: 3 women treated, 3 live births.

The big takeaway: fertility may not just be a hormonal “software” issue, it may be a mitochondrial hardware and energy issue.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

The Efficacy of Multiwavelength Red and Near-Infrared Transdermal Photobiomodulation Light Therapy in Enhancing Female Fertility Outcomes and Improving Reproductive Health: A Prospective Case Series with 9-Month Follow-Up

-

Key Quotes From Dr. Mike:

“What if the problem isn’t that women are running out of time? What if the problem is simply that they’re running out of energy?”

“If you could fix that energy problem, you might just be able to rewrite the entire code on fertility.”

“The human oocyte contains more mitochondria than any other cell in the body.”

“You are literally recharging the biological battery of the egg.”

“If you only used red light, you’d be treating the skin, but totally missing the engine room.”

“Perhaps the future of fertility… is simply about turning on the light.”

-

Key points

1. The episode reframes age-related infertility as an energy problem
   • Instead of only “biological clock” decline, the hosts argue fertility may be limited by mitochondrial energy capacity.
2. The paper focuses on a high-risk fertility demographic
   • Women ages 40–43, often labeled “poor prognosis,” with failed IVF and miscarriage histories.
3. The headline result is striking
   • In a small case series, the study reports 3 women treated, 3 live births (100%).
   • The hosts correctly note this is a very small sample size—but still a strong signal.
4. Egg cells are mitochondria-heavy
   • Oocytes contain far more mitochondria than most other cell types because they require enormous energy for meiosis and chromosomal segregation.
5. Mitochondrial decline may drive poor egg quality with age
   • As mitochondrial function declines, ATP output drops and chromosomal errors increase.
   • This contributes to aneuploidy, failed IVF, and miscarriage risk.
6. PBM is presented as a mitochondrial “fuel injection”
   • Red and near-infrared light stimulate cytochrome c oxidase, supporting ATP production and cellular energy.
7. The treatment target is not just the ovaries
   • The protocol treated:
     • Lower abdomen (ovaries/uterus)
     • Lower back/sacrum (nerve roots)
     • Neck/cervical region + clavicular lymph nodes (brainstem/vagus influence)
     • Gut/navel region (microbiome + estrogen metabolism)

8. The “proximal priority theory” is a key concept
   • Treating the neck may support the brain-hormone axis and vagus nerve, helping shift the body from stress mode to reproductive mode.
9. The protocol used multi-wavelength PBM
   • 660 nm red + near-infrared wavelengths (810/850/940 nm)
   • Red supports superficial tissues; near-infrared penetrates deeper to reach pelvic structures.
10. Case 1: recurrent miscarriage history → euploid embryos + live birth
    • A 41-year-old with miscarriages/molar pregnancy produced multiple blastocysts, including two euploid embryos, and had a live birth at 42.
11. Case 2: 4 failed IVF cycles → success after higher-frequency PBM
    • PBM every 2–3 days during stimulation; a day-3 fresh transfer succeeded, suggesting improved uterine receptivity.
12. Case 3: failed embryo transfer → natural conception after PBM
    • After a difficult IVF course and failed transfer, she did a PBM protocol for natural conception and conceived naturally.
13. Pregnancy safety was addressed cautiously
    • During early pregnancy support, the protocol was modified:
      • No abdominal treatment
      • Focus on cervical spine, lymph nodes, and feet
    • The hosts discuss penetration depth and systemic support rather than direct fetal exposure.
14. The larger thesis: fertility treatment often focuses on “software”
    • Hormones/manipulation = software
    • Mitochondria/blood flow/cellular energy = hardware
    • PBM is presented as a hardware-first strategy.

-

Episode timeline 

0:19–1:14 — Intro and paradigm shift setup

The hosts challenge the “biological clock” narrative and introduce the idea that infertility may be more about energy than time.

1:14–2:19 — Paper overview and study focus

Introduction to the 2024 PBM fertility paper and the core question: can light improve outcomes in women with prior IVF failure/miscarriage?

2:19–3:22 — Why this patient group matters

They highlight that the study focused on women 40–43, a group often considered poor prognosis, and preview the 3-for-3 live birth outcome.

3:22–6:33 — The mitochondria–fertility connection

Deep dive into why egg cells require so much energy, mitochondrial decline with age, and how ATP shortages may lead to chromosomal errors (aneuploidy).

6:33–8:33 — How PBM may help biologically

• Red/NIR light and cytochrome c oxidase
• ATP production
• Angiogenesis (VEGF)
• Improved uterine/ovarian blood flow
• Reduced inflammation

8:38–11:28 — The protocol: where they applied the light

Breakdown of treatment areas:

• Lower abdomen
• Lower back/sacrum
• Neck/cervical region + lymph nodes
• Gut/navel area

Includes discussion of vagus nerve and stress/reproductive state switching.

11:28–13:01 — Why multi-wavelength light matters

Explanation of 660 nm + 810/850/940 nm, penetration depth, and why one wavelength alone is insufficient for a systemic fertility protocol.

13:04–14:38 — Case 1: recurrent pregnancy loss → euploid embryos + live birth

A 41-year-old with a difficult history produces euploid embryos after PBM and delivers at age 42.

14:39–16:27 — Case 2: 4 failed IVF cycles → successful day-3 transfer

Higher-frequency PBM during stimulation appears to improve the uterine environment and support earlier embryo transfer success.

16:31–18:33 — Case 3: IVF setbacks → natural conception after PBM

A dramatic case where IVF setbacks are followed by a PBM protocol for natural conception, resulting in pregnancy.

18:39–20:17 — Safety discussion and protocol changes during pregnancy

How treatment was modified in early pregnancy (no abdominal treatment), plus discussion of penetration depth and maternal support.

20:18–22:32 — Big-picture interpretation: hardware vs software

The hosts summarize the 3 cases and argue fertility care often ignores the “hardware” (mitochondria, blood flow, energy).

22:32–23:45 — Closing reflections and final takeaway

PBM is framed as a non-invasive, drug-free way to energize the body and potentially support fertility by addressing root cellular energy issues.

24:00–24:14 — Outro / review request

Podcast close and call to follow/review.

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

 

BioLight:

Website

Instagram

YouTube

Facebook